1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Asia Pacific Typhoid Fever Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Asia Pacific Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Incidence and Mortality of Typhoid Accelerate Demand for Typhoid Conjugate Vaccines
5.2 Market Opportunities
- 5.2.1 Combination Vaccines
5.3 Future Trends
- 5.3.1 Government Support for the Typhoid Immunization to Favor Market
5.4 Impact of Drivers and Restraints
6. Asia Pacific Typhoid Fever Vaccines Market Regional Analysis
6.1 Asia Pacific Typhoid Fever Vaccines Market Overview
6.2 Asia Pacific Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Typhoid Fever Vaccines Market Forecast Analysis
7. Asia Pacific Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Asia Pacific Typhoid Fever Vaccines Market – Asia-Pacific Analysis
9.1 Asia-Pacific
- 9.1.1 Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 Asia Pacific Typhoid Fever Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 China:
Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 China: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.1.2 China: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.2 India:
Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 India: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.2.2 India: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.3 Japan:
Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Japan: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.3.2 Japan: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.4 Australia:
Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Australia: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.4.2 Australia: Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.5 Rest of Asia-Pacific :
Asia Pacific Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Asia Pacific Typhoid Fever Vaccines Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 GlaxoSmithKline plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Shanghai institute of biological products co., Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 PT Bio Farma
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BIO-MED
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BHARAT BIOTECH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Asia Pacific Typhoid Fever Vaccines Market
